Horák J, Cuparencu B
Res Commun Chem Pathol Pharmacol. 1994 Apr;84(1):119-22.
The intraperitoneal administration of flumazenil, an imidazoldiazepine with selective antagonistic properties on the central benzodiazepine receptors, induced in normoglycemic-normolipidemic rats a significant increase in blood glucose levels and significant decreases in the serum lipids.